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Abstract Leukotrienes are inflammatory mediators in-
volved in several diseases. The enzyme 5-lipoxygenase
initiates the synthesis of leukotrienes from arachidonic
acid. Little structural information is available regarding
5-lipoxygenase. In this study, we found that the primary
structure of the catalytic domain of human 5-lipoxyge-
nase is similar to that of the rabbit 15-lipoxygenase. This
similarity allowed the development of a theoretical model
of the tertiary structure of the 5-lipoxygenase catalytic
domain, using the resolved structure of rabbit 15-lipoxy-
genase as a template. This model was used in conjunction
with primary and secondary structural information to in-
vestigate putative nucleotide binding sites, a MAPKAP
kinase 2 phosphorylation site, and a Src homology 3
binding site on the 5-lipoxygenase protein, further. Re-
sults indicate that the putative nucleotide binding sites are
spatially distinct, with one on the β-barrel domain and the
other(s) on the catalytic domain. The MAPKAP kinase 2
phosphorylation site involves a four amino acid insertion
in mammalian 5-lipoxygenases that significantly alters
molecular structure. This target for post-translational
modification is both common and unique to 5-lipoxyge-
nases. The Src homology 3 binding site, found in all 
lipoxygenases, appears to lack the characteristic left-
handed type II helix structure of known Src homology 3
binding sites. These results, which highlight the unique
nature of the MAPKAP kinase site, underscore the utility
of structural information in the analysis of protein func-
tion. Electronic supplementary material to this paper can
be obtained by using the Springer LINK server located at
http://dx.doi.org/10.1007/s00894-002-0076-y.
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Introduction
Leukotrienes are lipid mediators with important roles in
normal host defense and inflammatory response [1, 2].
However, leukotriene overproduction contributes to a 
variety of diseases, including asthma [3, 4], allergic 
hyperresponsiveness [5], ulcerative colitis [6], psoriasis,
[7] rheumatoid arthritis, [8] and ischemic reperfusion in-
jury [9]. Understanding the regulation of overproduction
of leukotrienes should help elucidate the pathways of
pathogenesis for these diseases.
The enzyme 5-lipoxygenase (5-LO) plays the crucial
role of catalyzing the rate-limiting first two steps in the
synthesis of leukotrienes from arachidonic acid. As a re-
sult, there has been substantial interest in understanding
the mode of action of this key protein. It is well estab-
lished that nucleotides act as cofactors to stimulate 5-LO
activity [10] and a recent study has identified potential
binding sites for nucleotides on the 5-LO molecule [11].
A Src homology 3 (SH3) binding domain has been iden-
tified on 5-LO and shown to affect translocation [12].
Also, recent studies have shown that 5-LO can be phos-
phorylated by MAPKAP kinase 2, that phosphorylation
affects activity, and that 5-LO has a site that resembles
MAPKAP kinase 2 sites on other enzymes [13]. Infor-
mation regarding each of these sites, the nucleotide bind-
ing site(s), the SH3 binding domain, and the MAPKAP
kinase 2 phosphorylation site, is limited to the primary
amino acid sequence.
For all proteins, function depends on structure. The
crystal structure of 5-LO has yet to be elucidated. To
date, structural information for three lipoxygenases is
available, from the Research Collaboratory for Structural
Bioinformatics (http://www.rcsb.org/pdb). These include
rabbit reticulocyte 15-LO (1LOX [14]), the soybean LO,
LOX-1 (1YGE [15] and 2SBL [16]), and the soybean
LO, LOX-3 (1BYT [17] and 1LNH [18]). Comparison of
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the structure of the rabbit reticulocyte 15-LO with those
of the soybean LOX-1 and LOX-3 found that both mam-
malian and plant LOs are composed of two parts, an
amino-terminal β-barrel domain and a carboxy-terminal
domain composed predominantly of α-helices. Recent
studies have demonstrated that the β-barrel region is a
site for calcium binding [19, 20] and mediates membrane
association [21]. The carboxy-terminal domain contains
the iron that is essential for lipoxygenase activity and
thus is the catalytic domain. Previous studies have iden-
tified residues in the catalytic domain that are essential
for iron binding [22, 23], substrate positioning [14] and
nuclear import [24, 25]. Again, information regarding
these residues is largely limited to the primary amino ac-
id sequence. 
The absence of a 3-dimensional model for 5-LO has
prevented insights into structural contributions to enzy-
matic function. Computer algorithms have been devel-
oped to investigate protein structure, although the results
of applying these methods to 5-LO have not been pub-
lished. In this study, we compared the catalytic domain
of human 5-LO with those of rabbit reticulocyte 15-LO
and soybean LOX-1. Preliminary analysis indicated a
higher level of sequence similarity between the catalytic
domains of 5-LO and rabbit 15-LO than for the corre-
sponding β-barrel regions. As a result, our analysis fo-
cussed on the catalytic domain of 5-LO. The published
structure of rabbit 15-LO was used as a template to gen-
erate a theoretical model of the catalytic domain of hu-
man 5-LO. This structural model was then used to re-
evaluate previously described sites, including the nucleo-
tide binding site(s), the MAPKAP kinase 3 phosphoryla-
tion site, and the SH3 binding domain.
Materials and methods
Materials 
Amino acid sequences were obtained from Swiss-Prot from the
ExPASy (Expert Protein Analysis System) proteomics server of
the Swiss Institute of Bioinformatics. Primary accession numbers
for proteins are: for 5-LOs, human P09917, mouse P48999, rat
P12527, hamster P51399; for 15-LOs, rabbit P12530, human
P16050; for 12-LOs, bovine P27479, pig P16469, rat Q02759,
mouse leukocyte P39654, mouse platelet P18054; for soybeans,
LOX1 P08170, LOX3 P09186.
Alignment of protein sequences was performed using 
CLUSTALW [26], set for accurate method, Gonnet Matrix, gap
open penalty at 10, gap extension penalty at 0.1 (pairwise) and 0.2
(multiple). The Gonnet Matrix was used because it gave the high-
est overall alignment score; alignments obtained using either Pam
or Blosum are presented in the Supplemental Material.
Modeling by homology was performed by SWISS-MODEL 3.5
(http://www.expasy.ch/swissmod/SWISS-MODEL.html). Residues
121–673 from the human 5-LO protein sequence were submitted. If
submitted without a suggested template, rabbit reticulocyte 15-LO
(1LOX.pdb) was chosen by the Alignmaster program. Identical 
models were generated when 1LOX.pdb was specified as template
during sequence submission. Analysis of the generated model for the
catalytic domain of 5-LO was examined by the WHATIF program
version 19970813–1517 [27, 28].
Results
Primary structure
As noted above, LO proteins are known to be composed
of an N-terminal β-barrel domain and a C-terminal cata-
lytic domain [14, 15, 16, 18, 29]. In mammals, the β-bar-
rel region consists of ~110–120 amino acids and there is
a random coil of ~10 amino acids between the β-barrel
and catalytic domains. For this reason, D121 was arbi-
trarily chosen as the beginning of the catalytic domain
for human 5-LO. This sequence from 5-LO was aligned
with the full length sequences of rabbit 15-LO and soy
LOX-1 using CLUSTALW. [26] By this approach, D121
from 5-LO is appropriately aligned with G118 from 
15-LO, a residue between the last sheet of the β-barrel
domain and the first helix of the catalytic domain 
(Fig. 1a). However, this approach aligns 5-LO D121
with G235 from soy LOX-1, which omits ~85 residues
from the start of the LOX-1 catalytic domain. As a sec-
ond approach to alignment, CLUSTALW was used to
align the known catalytic domains of 15-LO and LOX-1
with amino acids 121–673 of 5-LO. This approach
aligned 5-LO D121 with soy LOX-1 E163, a residue ap-
propriately just beyond the last sheet of the soy β-barrel
region. This alignment resulted in 3 gaps of 19–32 amino
acids in the first 100 bases of both 5-LO and 15-LO, in-
dicating substantial differences in the catalytic domains
of the mammalian LOXs and the plant LOX (Fig. 1a).
CLUSTALW comparison of just the mammalian LOXs
(5-LO and 15-LO) gave a much higher sequence similar-
ity, with 40% identity, 63% positive and 0.36% gapped
(Fig. 1b). A more thorough CLUSTALW comparison of
catalytic domain sequences from human, mouse, rat and
hamster 5-LO with 15-LO from rabbit and human as
well as 12-LO from human, bovine, pig, rat and mouse
platelet, leukocyte and epidermal indicated that most of
the gaps were common and unique to the 5-LOs (data
not shown). That is, in all of the 5-LOs, there are identi-
cal insertions at or near residues 200, 265, 300, 465 and
580 and a gap at or near residue 328.
Theoretical model
The high similarity between the catalytic domains of hu-
man 5-LO and rabbit 15-LO indicated that the 15-LO
might be a good template for modeling the catalytic do-
main of 5-LO by homology. SwissModel 3.5 [30, 31, 32]
was used to generate the model, using the resolved struc-
ture for 15-LO (1LOX.pdb, [14] Fig. 2a) as a template.
As expected, the modeled catalytic domain of 5-LO
(Fig. 2b) superficially resembled the catalytic domain of
15-LO. The predicted protein was analyzed using the
WHATIF program version 19970813–1517 [27, 28] and
the results are summarized in Table 1. Z-scores present-
ed by WHATIF are the number of standard deviations
that the score deviates from the expected value; positive
structure z-scores are better than average, while RMS 
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Fig. 1 Alignment of the cata-
lytic domains of human 5-LO,
soybean LOX-1 and rabbit 
reticulocyte 15-LO. Catalytic
domains were aligned using
CLUSTALW. a) Alignment of
domains from all three pro-
teins. b) Alignment of 5-LO
with 15-LO. Upper and lower
numbers indicate residue num-
bers from 5-LO and 15-LO, 
respectively. 
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z-scores should be close to 1. All scores were rated as
acceptable by WHATIF except for the structure score for
2nd generation packing quality. The score of –3.79 was
interpreted as indicating that the protein is probably
threaded correctly, but either poorly refined, or it is just a
protein with an unusual (but correct) structure. To evalu-
ate the significance of the problems highlighted by the
WHATIF program, the sequence of the catalytic domain
of rabbit reticulocyte 15-LO was also submitted for 
modeling. As shown in Table 1, the scores from the 
corresponding WhatCheck analysis for modeling of the
15-LO sequence, using its own structure as a template,
were only moderately better than those obtained for 
5-LO. 
The structural elements for 5-LO, as predicted by
SwissModel, are summarized in Fig. 3 and Table 2.
Fig. 1b
106
(3, 7a, 7b, 11, 12, 17, 19) were found to run parallel to
one another, projecting toward the β-barrel domain 
(Fig. 4b). When further rotated downward approximately
45o, several other helices (1, 9, 14, 16, 18) were found to
run parallel to one another (Fig. 4c). 
A cluster of four antiparallel β-sheets was also ob-
served (Fig. 5). This cluster was found on both mamma-
lian and plant LOs. The overall structure of this cluster
on 5-LO was essentially identical to that on 15-LO 
(Fig. 5a, b). However, significant helical structure was
evident on an intervening loop of the plant LO, LOX 1
(Fig. 5c). The cluster was distal to the β-barrel domain
(Fig. 2).
Potential nucleotide binding sites
Affinity labeling has been used to identify potential
binding sites for nucleotides on 5-LO [11]. In those stud-
ies, one probe was found to bind at a mole ratio of 1.4,
whereas a second probe bound at 0.94, suggesting 1 or 2
binding sites. Two fragments of 5-LO (K73-K83 and
F193-K209) were frequently found to bind the probes;
W75 and W201 were modified, suggesting direct inter-
actions. A third, less common, 5-LO fragment, N315-
Q326, was also found. A common motif for nucleotide
binding is the P-loop, although not all nucleotide-bind-
ing proteins contain this P-loop [33]. None of the frag-
ments fits the consensus P-loop sequence ([AG]-x(4)-
G-K-[ST]). Similarly, they were not found to be similar
to any of the other nucleotide-, ATP-, or GTP-binding
sequence signatures (motifs listed at http://hits.isb-sib.
Table 1 Summary of protein structural analyses for catalytic do-
mains from human 5-LO and 15-LO, as performed by WHATIF.
The evaluation of the significance of each score, given in paren-
theses, was provided by WHATIF.
5-LO cat dom 15-LO cat dom
Structure Z-scores:
1st generation packing quality –1.835 (OK) –1.383 (OK)
2nd generation packing quality –3.790 (poor) –2.674 (OK)
Ramachandran plot appearance –1.366 (OK) –0.829 (OK)
chi-1/chi-2 rotamer normality 0.211 (OK) 0.400 (OK)
Backbone conformation –1.905 (OK) –1.268 (OK)
RMS Z-scores:
Bond lengths 0.764 (normal) 2.447 (loose)
Bond angles 1.186 (normal) 1.174 (normal)
Omega angle restraints 1.065 (OK) 0.753 (OK)
Side chain planarity 1.943 (OK) 3.311 (loose)
Improper dihedral distribution 1.387 (OK) 1.625 (loose)
Inside/Outside distribution 1.094 (normal) 1.074 (normal)
Table 2 Summary of major secondary structural elements from
15-LO (LOX1.pdb) and the theoretical model for the catalytic 
domain of 5-LO. Elements are named by first residue letter and
sequence number followed by last residue letter and number of
residues in the structure.
15-LO structure 5-LO Structure 
Number 
(5-LO)
Q125L14 helix K128Q14 1
K213S9 helix T217H9 2
D225N10 helix D229N10 3
L273D5 sheet I281D5 4
L300L6 sheet I309K6 5
L311Q7 sheet I320P3 X A324Q3 6A, 6B
P337L21 helix K344L26 7A
H365C14 helix H372Q14 7B
P384L10 helix P391V10 8
T396N10 helix T403A8 9
G424F12 helix G431M10 10
P443D7 helix F450A7 11
F459L23 helix Y470V20 12
D486R5 helix D496E5 13
L493T11 helix P503Y11 14
V522T14 helix R532A15 15
G538W13 helix A548N7 16
L573T7 helix E585T6 17
L583Q13 helix R594Q16 18
P617K27 helix K628K26 19Fig. 2 Comparison of the theoretical model for the catalytic 
domain of 5-LO with the resolved structure of 15-LO. a) Entire
15-LO molecule, from 1LOX.pdb. b) Theoretical model of the
catalytic domain of human 5-LO. 
Again as expected, helices and sheets in the 5-LO model
matched many of the structures of the soybean LOX
(Fig. 3a) and most of those of 15-LO (Fig. 3b). Notably,
helices of 5 or fewer aa were not recognized as helices
by SwissModel. Major structural elements included 16
α-helices. Two helices, labeled 7a and b, were separated
by two residues in the model but, in soy LOX3
(1LNH.pdb), form a single helix running through the
center of the domain. A cluster of β-sheets, labeled 4–6,
was located distal from the β-barrel region (Fig. 4a).
When rotated horizontally a quarter turn, several helices
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Fig. 3 Comparison of the 
secondary structural elements
predicted by the theoretical
model for 5-LO with those
from soy LOX1 and rabbit 
15-LO. a) 5-LO, LOX1 and 
15-LO. b) 5-LO vs. 15-LO.
Boxed areas indicate α-helices;
shaded areas indicate β-sheet
structure.
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ch/). However, the third fragment was found to be simi-
lar to the guanine-nucleotide dissociation stimulator 
motif (PS00741), which has a consensus sequence of
[LM]-x(2)-[LIVMFYW]-L-x(2)-P-[LIVM]-x(2)-[LIVM]-
x-[KRS]-x(2)-L-x-[LIVM]-x-[DEQ]-[LIVM]-x(3)-[ST]. 
Without information on tertiary structure, it was un-
clear whether these fragments cooperated in nucleotide
binding or represented distinct sites. As indicated in 
Table 3, the majority of the first fragment, and in particu-
lar W75, aligned with the random coil region between
two β-sheets on the β-barrel domain. The W75 residue
was found to be unique to the 5-LOs but replaced with R
on rat 5-LO. Again, in the second fragment, the aromatic
residue W201 was found on a random coil between two
structural elements, α-helices in this case. This residue
was found to be conserved across all mammalian LOXs.
The third fragment was completely conserved in all 
5-LOs but was poorly conserved across other LOXs. In
the predicted structure, the second and third fragments
appeared to be distinct from one another, as well as 
distant from the first fragment (Fig. 6a). The second
fragment, F193-K209, lost the helical structure found in
15-LO. Instead, it was a random coil between helices 2,
16 and 18. The third fragment spanned a loop between
two of the β-sheets in a cluster of sheets that were spa-
tially distant from the first two fragments. 
Fig. 3b
Legend see page 107
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The MAPKAP kinase 2 phosphorylation site
The MAPKAP kinase 2 phosphorylation motif of 5-LO
was previously identified based on similarity to sequenc-
es in two other proteins, heat shock protein 27 and lym-
phocyte-specific protein 1 [13]. The proteins share the
motif LxRxxS, with phosphorylation on the terminal S.
However, this motif, conserved across the 5-LOs, was
not examined in other LOs. Using CLUSTALW, this 
motif was found to be common as well as unique to all
5-LOs, resulting from an insertion of four amino acids
into the highly conserved LO sequence (Table 4). This
insertion occurs in the middle of a sequence that forms
an α-helix in rabbit 15-LO. The predicted structure in 
5-LO is not an α-helix, as in 15-LO. Instead, the key hy-
drophobic L266 residue projects inward and the putative
phosphorylation target, S271, is presented outward 
(Fig. 6b). The basic R268 is positioned between two
acidic residues, E263 and E275, a positioning that might
be expected to stabilize this structure and maintain S271
in an outward orientation.
The SH3 binding domain
The putative SH3 binding domain identified [12] and
characterized further [34] by Fitzpatrick and colleagues
was examined for structural characteristics. Essential
primary structural features of SH3 binding domains in-
cludes a PXXP motif, with each P preceded by an ali-
phatic residue (A, I, L or V), and an additional non-P,
typically R, forming part of the binding core that con-
tacts the SH3 domain [35, 36]. All of these features
were found to surround the PNAP core of 5-LO 
(Table 5). The primary sequence was extremely well
conserved in the 5-LOs. The key elements (core PNAP
Fig. 4 Organization of the catalytic domain of human 5-LO.
a) Localization of major structural elements, numbered sequential-
ly as in Table 2. b) Visualization of structural elements running
parallel to the central 7a and 7b helices, viewed on end. c) Helices
running parallel to one another and approximately 45° from the
central 7a and 7b helices.
Fig. 5 Comparison of β-sheet portions of catalytic domains of 
a) 5-LO, b) 15-LO and c) LOX1. Sheets run sequentially and 
antiparallel in all LOX proteins. Loops between sheets are very
similar in the mammalian LOXs.
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sequence, aliphatic residues preceding prolines, neigh-
boring R) were present in mammalian 12-LOs and 
15-LOs, as well. A single P (569) was consistently 
replaced with C in those LOs. Secondary structure char-
acteristics of SH3 binding domains involve the forma-
tion of a left-handed poly-P type II helix [37, 38]. The
resolved structure of 15-LO did not contain this struc-
ture (Fig. 6c). The predicted structure of 5LO, similarly
did not contain this structure (Fig. 6d). The affinity of
an SH3 binding peptide for its SH3 domain can be 
enhanced by contextual elements [39]. The predicted
structure of 5LO placed the PNAP core sequence close
to helices 7a, 17 and 18 (Fig. 6d). 
Discussion
In proteins, structure is critical to function. This study
presents the first model of the structure of the catalytic
domain of human 5-LO. Confidence in the general
strength of the model is supported by overall similarity
in primary and secondary structural characteristics to
rabbit 15-LO, regional similarity to soybean LOX1, and
a generally strong WHATIF analysis of the theoretical
model. The development of a model for 5-LO represents
a significant step toward understanding functional as-
pects of the 5-LO protein. Without a model, it has been
impossible to evaluate the significance of recent find-
ings, such as the putative nucleotide binding fragments.
The development of a theoretical model has helped to
highlight what appears to be a “lipoxygenase” tertiary
motif. Previous studies have noted that both plant and
animal LOs have the two domains, the β-barrel domain
and the catalytic domain. Also, two LO motifs in prima-
ry structure, both for iron binding, have been described.
These are LOX iron-binding signature 1 (PS00711): 
H-[EQ]-x(3)-H-x-[LM]-[NEQHRC]-[GSTA]-H-[LIVM-
STAC](2)-x-E; and LOX iron-binding signature 2
(PS00081): [LIVMAC]-H-P-[LIVM]-x-[KRQ]-[LIVMF]
(2)-x-[AP]-H. Together, these features have led to the
recognition of a lipoxygenase family of proteins (pfam
Table 3 Alignment of mammalian LOX sequences corresponding
to the putative nucleotide binding fragments from 5-LO. Align-
ments performed by CLUSTALW. Residues involved in an 
α-helix in r15-LO are boxed; residues forming a β-sheet are 
shaded. The specific fragments sequenced as nucleotide binding 
in human 5-LO are highlighted in bold.
Table 4 The 5-LO MAPKAP phosphorylation site: comparison
with primary sequences from various mammalian lipoxygenases.
Alignments performed by CLUSTALW. Residues forming an 
α-helix in r15-LO are boxed; residues forming a β-sheet are 
shaded.
Table 5 The 5-LO SH3 binding domain: comparison with primary
sequences from several mammalian lipoxygenases. Alignments
performed by CLUSTALW. Residues involved in helical structures
on r15-LO are boxed.
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PF00305 or INTERPRO entry IPR000907). The descrip-
tion of this family may be extended to incorporate tertia-
ry structure. The tertiary motif, as outlined in Results, in-
volves 5 α-helices running parallel to a central helix or
pair of continuing sub-helices (in this study, labeled 7a
and b). These helices are essentially perpendicular to the
β-barrel domain. Both of the iron-binding signatures are
located on the central helix or helix pair. In addition to
this group of helices, there is a second group of helices
which runs parallel to one another and at an angle of 
approximately 45° to the first group. Finally, there is also
a small cluster of β-sheets on the opposite end of the cat-
alytic domain from the β-barrel domain. These structures
are common to both the plant and animal LOs and thus
appear to provide a general overall structure.
The analysis presented provides some insight regard-
ing potential sites for nucleotide binding. Each fragment
is highly conserved across the different 5-LOs and shows
low homology with other mammalian LOXs. Also, the
three fragments appear to be spatially separated, indicat-
ing that they do not cooperate in nucleotide binding. A
common motif for nucleotide binding is the P-loop, 
although not all nucleotide-binding proteins contain this
P-loop [33]. None of the fragments fits the consensus 
P-loop sequence ([AG]-x(4)-G-K-[ST]). However, the
third fragment is similar to the guanine-nucleotide disso-
ciation stimulator motif (PS00741). Further work will
need to determine if any or all of these fragments actual-
ly bind nucleotides in vivo and how nucleotide binding
might be important for 5-LO function.
The finding that the RQLS sequence is unique to the
5-LOs stands in stark contrast to the high degree of simi-
larity between the LOs. This indicates that the function
of this site will be unique to the 5-LOs. The predicted
structure through this region of the 5-LOs, resulting in
the presentation of Ser271 to the cytoplasm, suggests
that this residue is highly accessible for phosphorylation.
These details strongly suggest that this site will be im-
portant in the function of the 5-LOs.
Regarding the SH3 binding domain, the high degree
of sequence similarity across the different mammalian
LOs suggests that this domain does not have a function
that is unique to the 5-LOs. On the other hand, the single
change from 569Pro in the 5-LOs to Cys in other mam-
malian LOXs may be a critical difference. Also, the 
15-LO structure and the 5-LO model indicate that this
domain does not have the characteristic left-handed
poly-Pro type II helix secondary structure. Finally,
neighboring structures may reduce accessibility. The
studies of Fitzpatrick and colleagues [12, 34] have dem-
onstrated that the SH3 binding domain of 5-LO can in-
teract with proteins containing SH3 domains. It is possi-
ble that the Pro for Cys replacement, found in the 5-LOs,
serves to position the SH3 binding domain closer to the
surface of the molecule. Alternatively, other events, such
as cofactor binding, might rearrange the neighboring
structures and in this way make the binding domain
more accessible.
In summary, we have developed a theoretical model
for the structure of the catalytic domain. This model 
allows inspection of specific residues and domains in 
the context of the three dimensional molecule. Such an
examination has indicated that the MAPKAP kinase
phosphorylation site of the 5-LOs represents a site that is
unique to the 5-LOs and appears to be structurally con-
sistent with functional significance. In contrast, the puta-
tive nucleotide binding fragments appear to be distinct
sites which lack structural similarity to other nucleotide
Fig. 6 Localization of func-
tional elements of the catalytic
domain. a) The putative nucle-
otide binding fragments on the
catalytic domain of 5-LO. 
b) The MAPKAP 2 phosphory-
lation site. c) Region, on rabbit
15-LO, corresponding to the
SH3-binding domain of 5-LO.
d) SH3-binding domain on the
catalytic domain of 5-LO.
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binding domains and thus require further examination.
The theoretical model should be similarly useful in other
analyses of 5-LO structure and function.
Supplementary material
1 Sequence alignments obtained using different matrices
with CLUSTALW is available in the supplementary
material.
2 The source of most images is available as a pdf-file in
the supplementary material.
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